Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience
ALERT

FREE Webinar for FA’s and RIA’s — Reserve Your Seat Now!

Mutualfunds logo

EMHSX Eaton Vance Worldwide Health Sci B

  • Fund
  • EMHSX
  • Price as of: Dec 02, 2016
  • $10.29
  • + $0.04
  • + 0.39%
  • Category
  • Health & Biotech Equities

EMHSX - Profile

Vitals

  • YTD Return -17.5%
  • 3 Yr Annualized Return -7.3%
  • 5 Yr Annualized Return 1.0%
  • Net Assets $1.23 B
  • Holdings in Top 10 42.2%

52 WEEK LOW AND HIGH

$10.29
$10.20
$13.37

Expenses

OPERATING RELATED FEES

  • Expense Ratio 2.23%

SALES FEES

  • Front Load N/A
  • Deferred Load 5.00%

BROKERAGE FEES

  • Turnover 70.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

Closed to new investors as of 2012-01-02

STANDARD (TAXABLE)

$1,000

IRA

$1,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -17.5%
  • 3 Yr Annualized Total Return 7.0%
  • 5 Yr Annualized Total Return 27.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -1.40%
DIVIDENDS
  • Dividend Yield 0.1%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Eaton Vance Worldwide Health Sciences Fund
  • Fund Family Name Eaton Vance
  • Inception Date Sep 23, 1996
  • Shares Outstanding N/A
  • Share Class B
  • Currency USD
  • Domiciled Country United States
  • Manager Jason A. Kritzer

EMHSX - Performance

Return Ranking - Trailing

Period EMHSX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -17.5% -30.9% 7.4% 83.04% 5
1 Yr -23.7% -31.1% 18.4% 91.89% 5
3 Yr -7.3% * -17.6% 17.2% 90.74% 5
5 Yr 1.0% * -5.6% 21.9% 94.06% 5
10 Yr -1.6% * -2.7% 14.3% 96.34% 5

* Annualized


Return Ranking - Calendar

Period EMHSX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -1.9% -20.4% 13.8% 43.64% 3
2014 8.8% -5.9% 31.5% 72.73% 4
2013 28.2% 0.0% 65.2% 76.15% 4
2012 0.0% -5.3% 36.5% 87.38% 5
2011 -5.5% -15.5% 18.8% 76.47% 5

Total Return Ranking - Trailing

Period EMHSX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -17.5% -23.6% 7.4% 85.59% 5
1 Yr -16.5% -30.7% 10.5% 77.27% 4
3 Yr 7.0% * -17.6% 19.3% 65.74% 4
5 Yr 27.9% * -5.6% 147.5% 30.30% 2
10 Yr 22.5% * -2.3% 37.3% 13.92% 1

* Annualized


Total Return Ranking - Calendar

Period EMHSX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 8.1% -16.6% 20.7% 45.87% 3
2014 35.9% -5.8% 55.3% 45.87% 3
2013 84.9% 0.0% 398.7% 35.19% 2
2012 42.2% -5.1% 475.8% 47.00% 3
2011 13.1% -10.2% 2296.2% 53.61% 3

NAV & Total Return History

EMHSX - Holdings

Filings data as of: Sep 30, 2016

Concentration Analysis

EMHSX Category Low Category High EMHSX % Rank Quintile
Net Assets 1.23 B 20.5 M 43.6 B 16.07% 3
Number of Holdings 44 31 345 24.11% 5
Net Assets in Top 10 582 M 9.55 M 20.9 B 16.96% 3
Weighting of Top 10 42.2% 21.8% 71.5% 18.75% 3

Top 10 Holdings

  1. Allergan PLC 5.86%
  2. Eli Lilly and Co 5.14%
  3. Roche Holding AG Dividend Right Cert. 5.82%
  4. Novo Nordisk A/S B 3.25%
  5. Medtronic PLC 4.17%
  6. Johnson & Johnson 3.86%
  7. Biogen Inc 3.78%
  8. Gilead Sciences Inc 3.65%
  9. Celgene Corp 3.37%
  10. Shire PLC 3.29%

Asset Allocation

Weighting Category Low Category High EMHSX % Rank Quintile
Stocks
98.66% 82.12% 103.35% 12.50% 2
Cash
1.33% 0.00% 16.35% 14.29% 3
Other
0.00% -3.35% 10.27% 16.96% 5
Convertible Bonds
0.00% 0.00% 0.38% 3.57% 5
Preferred Stocks
0.00% 0.00% 0.96% 4.46% 5
Bonds
0.00% 0.00% 1.91% 5.36% 5

Stock Sector Breakdown

Weighting Category Low Category High EMHSX % Rank Quintile
Healthcare
98.67% 13.15% 99.87% 2.68% 1
Financial Services
0.00% 0.00% 1.00% 6.25% 5
Real Estate
0.00% 0.00% 1.97% 2.68% 5
Industrials
0.00% 0.00% 13.35% 12.50% 5
Utilities
0.00% 0.00% 1.10% 1.79% 5
Technology
0.00% 0.00% 64.83% 24.11% 5
Energy
0.00% 0.00% 0.00% 0.89% 5
Communication Services
0.00% 0.00% 1.73% 1.79% 5
Consumer Defense
0.00% 0.00% 2.38% 12.50% 5
Consumer Cyclical
0.00% 0.00% 3.21% 7.14% 5
Basic Materials
0.00% 0.00% 4.92% 4.46% 5

Stock Geographic Breakdown

Weighting Category Low Category High EMHSX % Rank Quintile
US
81.12% 60.81% 99.87% 25.00% 4
Non US
17.54% 0.00% 41.10% 8.93% 2

EMHSX - Expenses

Operational Fees

EMHSX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 2.23% 0.10% 4.31% 8.04% 5
Management Fee 0.94% 0.08% 1.25% 5.36% 5
12b-1 Fee 1.00% 0.00% 1.00% 1.28% 5
Administrative Fee 0.15% 0.01% 0.40% 6.15% 4

Sales Fees

EMHSX Fees (% of AUM) Category Low Category High EMHSX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load 5.00% 1.00% 5.00% 3.13% 5

Trading Fees

EMHSX Fees (% of AUM) Category Low Category High EMHSX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

EMHSX Fees (% of AUM) Category Low Category High EMHSX Rank Quintile
Turnover 70.00% 7.00% 249.00% 9.82% 4

EMHSX - Distributions

Dividend Yield Analysis

EMHSX Category Low Category High EMHSX % Rank Quintile
Dividend Yield 0.1% 0.01% 0.94% 34.04% 2

Dividend Distribution Analysis

EMHSX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

EMHSX Category Low Category High EMHSX % Rank Quintile
Net Income Ratio -1.40% -2.22% 1.40% 66.07% 5

Capital Gain Distribution Analysis

EMHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

EMHSX - Managers

Jason A. Kritzer

Manager

Start Date

Jul 01, 2016

Tenure

0.33

Tenure Rank

22.7%

Kritzer, CFA, is Vice President and Research Analyst of BlackRock’s Large Cap Growth Equity team since June 2006. Prior thereto, he was Senior Vice President and equity research analyst at Putnam Investments.


Samantha Pandolfi

Manager

Start Date

Jul 01, 2016

Tenure

0.33

Tenure Rank

22.7%

Ms. Pandolfi Prior to joining EVMI as a Vice President in November 2015, Ms. Pandolfi was a Portfolio Manager and Research Analyst with Goldman Sachs Asset Management over her fifteen year tenure


Tenure Analysis

Category Low

0.0

Category High

19.1

Category Average

8.78

Category Mode

4.8